Abstract 7299: CS2009: A first-in-class trispecific antibody targeting PD-1, CTLA-4, and VEGFA with potential to be a next-generation backbone therapy with combined checkpoint inhibition and anti-angiogenesis
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Chuan Wang, Ning Zhang, Yilin Huo, Xinling Zhang, Yongwang Li, Jingyu Sun, Xuelian Liu, Yongli Yang, Xueqin Dai, Yuxin Qian, Fei Ma, Yi Sun, Yujuan La, Jianxin Yang
Institution: CStone Pharmaceuticals (China)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630635